HYPR
Hyperfine, Inc.NASDAQHealthcare$1.13+3.67%ClosedMarket Cap: $92.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.62
P/S
6.87
EV/EBITDA
-1.56
DCF Value
$-1.78
FCF Yield
-31.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.8%
Operating Margin
-273.4%
Net Margin
-262.3%
ROE
-97.4%
ROA
-64.4%
ROIC
-84.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.3M | 50.9% | $-7.7M | $-5.9M | $-0.06 | — |
| FY 2025 | $13.6M | 49.8% | $-37.1M | $-35.6M | $-0.43 | — |
| Q3 2025 | $3.4M | 53.8% | $-8.9M | $-11.0M | $-0.14 | — |
| Q2 2025 | $2.7M | 49.3% | $-9.6M | $-9.2M | $-0.12 | — |
| Q1 2025 | $2.1M | 41.3% | $-10.9M | $-9.4M | $-0.12 | — |
| Q4 2024 | $2.3M | 35.6% | $-10.8M | $-10.4M | $-0.14 | — |
| FY 2024 | $12.9M | 45.7% | $-43.2M | $-40.7M | $-0.56 | — |
| Q3 2024 | $3.6M | 52.4% | $-11.0M | $-10.3M | $-0.14 | — |
| Q2 2024 | $3.6M | 49.7% | $-10.8M | $-10.2M | $-0.14 | — |
| Q1 2024 | $3.3M | 41.1% | $-10.7M | $-9.8M | $-0.14 | — |
| Q4 2023 | $2.7M | 38.5% | $-11.6M | $-10.7M | $-0.15 | — |
| FY 2023 | $11.0M | 43.1% | $-48.1M | $-44.2M | $-0.62 | — |